Cargando…
Genetic Variants and Drug Efficacy in Tuberculosis: A Step toward Personalized Therapy
Tuberculosis (TB) continues to be a major infectious disease affecting individuals worldwide. Current TB treatment strategy recommends the standard short-course chemotherapy regimen containing first-line drug, i.e., isoniazid, rifampicin, pyrazinamide, and ethambutol to treat patients suffering from...
Autores principales: | Khan, Almas, Abbas, Mohammad, Verma, Sushma, Verma, Shrikant, Rizvi, Aliya Abbas, Haider, Fareya, Raza, Syed Tasleem, Mahdi, Farzana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9192167/ https://www.ncbi.nlm.nih.gov/pubmed/35707778 http://dx.doi.org/10.1055/s-0042-1743567 |
Ejemplares similares
-
Determinants in Tailoring Antidiabetic Therapies: A Personalized Approach
por: Rizvi, Aliya A., et al.
Publicado: (2022) -
Impact of I/D polymorphism of angiotensin-converting enzyme 1 (ACE1) gene on the severity of COVID-19 patients
por: Verma, Sushma, et al.
Publicado: (2021) -
Association of Genetic polymorphism of PPARγ-2, ACE, MTHFR, FABP-2 and FTO genes in risk prediction of type 2 diabetes mellitus
por: Abbas, Shania, et al.
Publicado: (2013) -
Polymorphism of CYP46A1 and PPARγ2 Genes in Risk Prediction of Primary Open Angle Glaucoma Among North Indian Population
por: Chandra, Anu, et al.
Publicado: (2016) -
Association of angiotensin-converting enzyme, CYP46A1 genes polymorphism with senile cataract
por: Raza, Syed Tasleem, et al.
Publicado: (2017)